If no other option help...
Key Market Indicator:
F&G: 63
25.547,95 NASDAQ · 49.390,00 DOW · 6.947,26 S&P · 4.596,86 Gold · 63,45 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
© Newsfile
09.01.2026
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group's Rosie's Burgers Announces the Grand Opening of Its Newest Location in Calgary's Marda Loop Neighbourhood
Article
News Preview
Toronto, Ontario--(Newsfile Corp. - January 9, 2026) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging restaurant brands, is pleased to announce the grand opening of its newest Rosie's Burgers ("Rosie's") restaurant this Saturday, January 10th, located in the highly sought-...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva und BioMarin schließen langfristige strategische Partnerschaft
Article
News Preview
Partnerschaft zur Unterstützung von BioMarin bei der Beschleunigung und Effizienzsteigerung der Entwicklung und Vermarktung innovativer TherapienPLEASANTON, Kalifornien, und SAN RAFAEL, Kalifornien, 9. Januar 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) und BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) gaben eine langfristige Unternehmensvereinba...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: NL0010696654
Uniqure NV
QURE
LISTED
NASDAQ
uniQure Announces Type A Meeting Scheduled with FDA
Article
News Preview
LEXINGTON, Mass. and AMSTERDAM, Jan. 09, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced a Type A meeting with the U.S. Food and Drug Administration (FDA) has been scheduled to discuss the Biologics License Application (...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
09.01.2026
ISIN: US67577C1053
Ocugen Inc
OCGN
LISTED
NASDAQ
Ocugen CEO to Present at J.P. Morgan 2026 Healthcare Conference
Article
News Preview
MALVERN, Pa., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founder of Ocugen, will present at the 44th Annual J.P. Morgan Healthcare Conference taking place January...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© BusinessWire
09.01.2026
ISIN: US49372L2097
Kezar Life Sciences Inc
KZR
LISTED
NASDAQ
Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
Article
News Preview
Kezar Life Sciences, Inc. (Nasdaq:KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that the Food and Drug Administration (FDA) Division of Hepatology and Nutrition has granted Kezar a Type C meeting for the first quarter to discuss the develo...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US04746L1044
Athira Pharma, Inc
ATHA
LISTED
NASDAQ
Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA”
Article
News Preview
Athira Pharma, Inc. today announced that it has changed its name to LeonaBio, Inc....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US46489V1044
IsoRay, Inc.
ISR
LISTED
XASE
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium
Article
News Preview
SEATTLE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company that is pioneering advanced treatments for cancers throughout the body, announced updated interim results from its ongoing Phase 1/2a clinical trial of [21...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US45258D1054
Immunocore Holdings plc
IMCR
LISTED
NASDAQ
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference
Article
News Preview
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US03843E1047
Aquestive Therapeutics Inc
AQST
LISTED
NASDAQ
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
Article
News Preview
WARREN, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today provided an update on the regulatory approval of Anaphylm™ and its b...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US45107K1025
iBio Inc
IBIO
LISTED
NASDAQ
iBio Announces $26 Million Private Placement
Article
News Preview
SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality institutional investors for a private placement ("PIPE") financing that is expected to result in gros...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US56565P1030
MapLight Therapeutics, Inc
MPLT
LISTED
NASDAQ
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Article
News Preview
SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS clinical studies, which are progressing ahead of schedule....
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 
Article
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it will report financial results for the fourth quarter and full year of 2025 on February 18, 2026, before the opening of the financial markets. In connection with the release, mana...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
09.01.2026
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Corporation Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update
Article
News Preview
MORRISVILLE, N.C., Jan. 09, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today announced preliminary, unaudited full-year 2025 net product sales of YUTREPIA™ (treprostinil) inhalatio...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US7504911022
RadNet Inc
RDNT
LISTED
NASDAQ
RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
Article
News Preview
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice Pr...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: SE0002190926
Karolinska Development AB
KDEV
LISTED
STO
Karolinska Development AB (publ) announces publication of information document in connection with upcoming rights issue
Article
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, JAPAN, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH KOREA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US80303D3052
SANUWAVE Health, Inc.
SNWV
LISTED
NASDAQ
Sanuwave Health Announces Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue
Article
News Preview
Sanuwave Health Reports Preliminary Q4 2025 Revenue of $13.3–$13.4 Million, Up 29–30% Year-over-Year; Achieves Record Quarterly and Full-Year Revenue...
Themefolio
Profiler
Peergroup
© EQS Newswire
09.01.2026
ISIN: DE0005785802
Fresenius Medical Care AG
FME
LISTED
XETR
Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
Article
News Preview
Bad Homburg, 9. Januar 2026 – Die Fresenius Medical Care AG („Gesellschaft“) hat entschieden, den Rückerwerb der zweiten Tranche des mit einer Ad-hoc-Mitteilung vom 17. Juni 2025 bekanntgegebenen Aktienrückkaufprogramms zu starten. Das Aktienrückkaufprogramm hat ein Volumen von insgesamt EUR 1 Milliarde (ohne Erwerbsnebenkosten). Die erste Tranche......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
09.01.2026
ISIN: US03835L2079
Aptevo Therapeutics Inc.
APVO
LISTED
NASDAQ
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Article
News Preview
Together with cash on hand, the fully leveraged facility extends Aptevo's funding runway into 2029, enabling achievement of key clinical and preclinical milestones SEATTLE, WA / ACCESS Newswire / January 9, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: SE0006887451
Corline Biomedical AB
CLBIO
LISTED
STO
CorlineCorline Biomedical stärker samarbetet med Kardium – genomför riktad emission och upptar lån från Kardium för att mångfaldiga produktionskapaciteten
Article
News Preview
EJ FÖR PUBLICERING, DISTRIBUTION, ELLER OFFENTLIGGÖRANDE, DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAPAN, KANADA, NYA ZEELAND, SCHWEIZ, SINGAPORE, SYDAFRIKA, SYDKOREA ELLER NÅGON ANNAN STAT ELLER JURISDIKTION I VILKEN SÅDAN ÅTGÄRD SKULLE VARA OLAGLIG ELLER INNEBÄRA KRAV PÅ ANDRA ÅTGÄRDER....
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse
Article
News Preview
Transgene Publishes Phase I Data Supporting TG4050’s Potential in Preventing Head and Neck Cancer Relapse...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
Article
News Preview
Press release – No. 2 / 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: CH0012100191
Tecan Group AG
TECN
LISTED
SIX
Tecan reports return to sales growth and strong order entry in the second half of 2025
Article
News Preview
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva stellt eine Umweltüberwachungslösung zur Modernisierung der Qualitätskontrolle in der Fertigung vor
Article
News Preview
Die erweiterten QC-Lösungen von Veeva für die Fertigung automatisieren die Sammlung und Analyse von UmweltprobenBARCELONA, Spanien, 9. Januar 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) kündigte heute eine neue Lösung zur Umweltüberwachung (EM) an, um die Qualitätskontrolle (QC) in der Produktion zu verbessern. Veeva Environmental Monitoring i...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.01.2026
ISIN: US61225M1027
Monte Rosa Therapeutics Inc
GLUE
LISTED
NASDAQ
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
Article
News Preview
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
ISIN: US4781601046
Johnson & Johnson
JNJ
LISTED
NYSE
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
Article
News Preview
Johnson & Johnson (NYSE: JNJ) (the “Company”), healthcare’s leading, most comprehensive innovation powerhouse, today announced a voluntary agreement with the Trump Administration to improve access to medicines and lower costs for millions of American patients. The joint agreement meets the requests laid out by President Trump to the industry a...
Themefolio
Profiler
Peergroup
© Newsfile
09.01.2026
ISIN: CA2046632071
Comprehensive Healthcare Systems Inc.
CHS
LISTED
TSX
Comprehensive Healthcare Systems Inc. Announces Non-Brokered Private Placement and Shares for Debt Settlement
Article
News Preview
Calgary, Alberta--(Newsfile Corp. - January 8, 2026) - Comprehensive Healthcare Systems Inc. (TSXV: CHS) (OTCQB: CMHSF) (the "Company" or "CHS"), an industry leader in healthcare benefits administration software and services, is pleased to announce a non-brokered private placement (the "Offering") of up to 7,000,000 units (the "Units") at a price o...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
ISIN: KYG4818G1010
Innovent Biologics Inc
1801
LISTED
HKSE
Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration
Article
News Preview
SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today...
Themefolio
Profiler
Peergroup
© BusinessWire
09.01.2026
ISIN: US87961M1053
Telix Pharmaceuticals Ltd (ADR)
TLX
LISTED
NASDAQ
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
Article
News Preview
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”) of the important January 9, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2026
ISIN: US1124631045
Brookdale Senior Living Inc
BKD
LISTED
NYSE
Brookdale Announces Beneficial Financing Transactions; Successfully Refinances 2026 and a Portion of 2027 Mortgage Debt
Article
News Preview
BRENTWOOD, Tenn., Jan. 8, 2026 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or "the Company") announced today that the Company recently completed a series of financing transactions with multiple lenders totaling approximately $600 million. Through these transactions, the Company refinanced all of its approximately $350 mil...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US38341P1021
Gossamer Bio Inc
GOSS
LISTED
NASDAQ
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that the Compensation Committee of Gossamer’s B...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Article
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 44th Annual J.P. M...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US0327241065
AnaptysBio Inc
ANAB
LISTED
NASDAQ
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary
Article
News Preview
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, I...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US2074101013
Conmed Corp
CNMD
LISTED
NYSE
CONMED Corporation Announces Chief Financial Officer Transition
Article
News Preview
CONMED Corporation (NYSE: CNMD) today announced the departure of Todd Garner from his role as Chief Financial Officer effective March 15, 2026. To ensure a smooth and orderly transition, Mr. Garner will remain with the Company in an advisory capacity through November 2, 2026. CONMED has initiated a comprehensive search process, supported by a le...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina Appoints Dr. Eric Green as Chief Medical Officer
Article
News Preview
Veteran genomics leader joins Illumina to advance global medical strategyIllumina chief commercial officer to depart for role as a life science tools company CEO SAN DIEGO, Jan. 8, 2026 /PRNewswire/ -- Today, Illumina, Inc. (NASDAQ: ILMN) announced the appointment of Eric D. Green, M.D., Ph.D., as Chief Medical Officer (CMO), effective February 2...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: US69366J2006
PTC Therapeutics Inc
PTCT
LISTED
NASDAQ
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
WARREN, N.J., Jan. 8, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Jan. 2, 2026, the company approved 300 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to a new non-executive employee. The award was made pursuant to the Nasdaq inducement gra...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US74766Q1013
Quanterix Corp
QTRX
LISTED
NASDAQ
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
Article
News Preview
Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its Board of Directors (the “Board”) has appointed Everett Cunningham as the Company’s next President and Chief Executive Officer and a member of the Boar...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Schedules Fourth Quarter 2025 Earnings Call
Article
News Preview
BREA, Calif., Jan. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2025 on Thursday, February 5, 2026. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. ...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: US09061G1013
BioMarin Pharmaceutical Inc
BMRN
LISTED
NASDAQ
BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA
Article
News Preview
SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will present at the 44th Annual J.P. Morgan Conference on Monday, January 12, 2026, at 11:15 am PT / 2:15 pm ET, in San Francisco, California. The Company plans to ann...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
Article
News Preview
PLEASANTON, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conference: J.P. Morgan 2026 Healthcare Conference, San Francisco, CA. Brian Van Wagener, CFO, will present on Tuesday, January 13, 2026, at 1:30 p.m. Pacific Time.The above presentation will be webcast. Links to the...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates
Article
News Preview
Preliminary unaudited fourth quarter and full year 2025 net product revenue of approximately $22M and $73M respectively; cash and cash equivalents of approximately $261M as of December 31, 2025, provide expected cash runway at least to 2028Anticipated near-term catalysts include LOTIS-7 complete enrollment in first half of 2026 and LOTIS-5 Phase 3...
Themefolio
Profiler
Peergroup
© PR Newswire
08.01.2026
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals Appoints Thomas Riga as Chief Business Officer
Article
News Preview
Mr. Riga brings over 25 years of commercial and operational experience with proven success leading transformative corporate development strategies and transactionsDUBLIN, Jan. 8, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Thomas Riga as Chief Business Officer, effective January 1, 2026.Mr. Riga...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
Article
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its first quarter fiscal 2026, ended November 30, 2025. First Quarter 2026 Financial Highlights (as compared to first quarter 20...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
PANTHERx® Rare Selected by Savara as the U.S. Exclusive Specialty Pharmacy for MOLBREEVI*
Article
News Preview
PANTHERx® Rare Pharmacy, the trusted leader and innovator in patient access and support services for personalized rare disease care, and Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced an exclusive distribution agreement for MOLBREEVI. Savara submitted the MOLBREEVI BLA to the...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Update on Strong EKTERLY® Launch with Preliminary Fourth Quarter and Full Year 2025 Revenue Results
Article
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided its preliminary fourth quarter and full year ended December 31, 2025 unaudited global net product revenue results and other operational indicators. “We are extremely pleased with our performance since launching EKTERLY in July, which reflects steady execution, growing utilization, and...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
Article
News Preview
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pac...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US45257U1088
Immunome Inc
IMNM
LISTED
NASDAQ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on January 2, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards consisting of non-statutory stock o...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US92790C1045
Viridian Therapeutics Inc
VRDN
LISTED
NASDAQ
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Article
News Preview
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the Compensation Committee of the company’s Board of Directors, made up entirely of independent directors, approved the grant of non-qualifi...
Themefolio
Profiler
Peergroup
© BusinessWire
08.01.2026
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
Article
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AGILON HEA...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US74006W1080
Praxis Precision Medicines Inc
PRAX
LISTED
NASDAQ
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Article
News Preview
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation–inhibition imbalance, today announced the appointment of Jeffrey B. Kin...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
Article
News Preview
GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax® (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent’s existing indefinite-delivery/indefinite-quantity (IDIQ) contrac...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US58510H1032
MEDIROM Healthcare Technologies Inc.
MRM
LISTED
NASDAQ
World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku’s “Orb” Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately Two Months
Article
News Preview
TOKYO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Headquarters: Minato-ku, Tokyo; CEO: Kouji Eguchi; NASDAQ: MRM, MEDIROM or the “Company”), announces that the cumulative number of Proof of Human authentications using the World ID authentication device ‘Orb’ at stores centered on the relaxation salon “Re.Ra.Ku,” opera...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Article
News Preview
Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US4525253062
ImmuCell Corporation
ICCC
LISTED
NASDAQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Article
News Preview
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, today announced preliminary, unaudited sales results for the fourth quarter and full year of 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US89455T1097
Treace Medical Concepts Inc
TMCI
LISTED
NASDAQ
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
Article
News Preview
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its Lapiplasty® Lightn...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US28617K1016
Eledon Pharmaceuticals, Inc.
ELDN
LISTED
NASDAQ
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
Article
News Preview
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US88688T1007
Tilray Brands, Inc.
TLRY
LISTED
TSX
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
Article
News Preview
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6%...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
Article
News Preview
SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit’s Lead Independent Director, as Chair of the Board effective January 5, 2026....
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US00773J2024
Spyre Therapeutics Inc
SYRE
LISTED
NASDAQ
Spyre Therapeutics Announces Grants of Inducement Awards
Article
News Preview
WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease and rheumatic diseases, today announced that Spyre’s independent Co...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Article
News Preview
SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Oth...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2026
ISIN: US81734D1046
Septerna, Inc.
SEPN
LISTED
NASDAQ
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer
Article
News Preview
Septerna, Inc. announced the appointment of Mark A. Wilson as Chief Legal Officer....
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 18.01.2026, Calendar Week 03, 18th day of the year, 347 days remaining until EoY.